Terms: = Germ cell tumor AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Clinical Outcome
20 results:
1. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and tert promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract] [Full Text] [Related]
2. MYCN amplification, tert rearrangements and ATRX mutations in neuroblastoma: clinicopathological correlates- an Indian perspective.
Kerkar AN; Chinnam D; Verma A; Peters NJ; Kakkar N; Trehan A; Singh M; Gupta K
Virchows Arch; 2023 Oct; 483(4):477-486. PubMed ID: 37460674
[TBL] [Abstract] [Full Text] [Related]
3. Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond.
Kresbach C; Neyazi S; Schüller U
Brain Pathol; 2022 Jul; 32(4):e13068. PubMed ID: 35307892
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of
van Ipenburg JA; Naus NC; Dubbink HJ; van Ginderdeuren R; Missotten GS; Paridaens D; Verdijk RM
Br J Ophthalmol; 2021 Oct; 105(10):1454-1461. PubMed ID: 33127831
[TBL] [Abstract] [Full Text] [Related]
5. Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients.
Marczynski GT; Laus AC; Dos Reis MB; Reis RM; Vazquez VL
Sci Rep; 2020 Oct; 10(1):18682. PubMed ID: 33122747
[TBL] [Abstract] [Full Text] [Related]
6. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts.
Galbraith K; Kumar A; Abdullah KG; Walker JM; Adams SH; Prior T; Dimentberg R; Henderson FC; Mirchia K; Sathe AA; Viapiano MS; Chin LS; Corona RJ; Hatanpaa KJ; Snuderl M; Xing C; Brem S; Richardson TE
J Neuropathol Exp Neurol; 2020 Aug; 79(8):843-854. PubMed ID: 32647886
[TBL] [Abstract] [Full Text] [Related]
8. Telomere Maintenance Mechanisms Define clinical outcome in High-Risk Neuroblastoma.
Koneru B; Lopez G; Farooqi A; Conkrite KL; Nguyen TH; Macha SJ; Modi A; Rokita JL; Urias E; Hindle A; Davidson H; Mccoy K; Nance J; Yazdani V; Irwin MS; Yang S; Wheeler DA; Maris JM; Diskin SJ; Reynolds CP
Cancer Res; 2020 Jun; 80(12):2663-2675. PubMed ID: 32291317
[TBL] [Abstract] [Full Text] [Related]
9. Targetable molecular alterations in congenital glioblastoma.
Gilani A; Donson A; Davies KD; Whiteway SL; Lake J; DeSisto J; Hoffman L; Foreman NK; Kleinschmidt-DeMasters BK; Green AL
J Neurooncol; 2020 Jan; 146(2):247-252. PubMed ID: 31875306
[TBL] [Abstract] [Full Text] [Related]
10. Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features.
Zhang L; Liu Z; Li J; Huang T; Wang Y; Chang L; Zheng W; Ma Y; Chen F; Gong X; Yuan Q; Teaw S; Fang X; Song T; Huo L; Li X; Xia X; Liu Z; Wu J
Sci Rep; 2019 Nov; 9(1):16058. PubMed ID: 31690770
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas.
Zhang ZY; Zhan YB; Zhang FJ; Yu B; Ji YC; Zhou JQ; Bai YH; Wang YM; Wang L; Jing Y; Duan WC; Sun C; Sun T; Zhao HB; Li K; Wang WQ; Li RY; Sun HW; Zhai G; Wang SK; Wei XT; Yang B; Yan DM; Liu XZ; Wang WW
Aging (Albany NY); 2019 Aug; 11(16):6252-6272. PubMed ID: 31444316
[TBL] [Abstract] [Full Text] [Related]
12. SEL1L plays a major role in human malignant gliomas.
Mellai M; Annovazzi L; Boldorini R; Bertero L; Cassoni P; De Blasio P; Biunno I; Schiffer D
J Pathol Clin Res; 2020 Jan; 6(1):17-29. PubMed ID: 31111685
[TBL] [Abstract] [Full Text] [Related]
13. Molecular classification of IDH-mutant glioblastomas based on gene expression profiles.
Wu F; Chai RC; Wang Z; Liu YQ; Zhao Z; Li GZ; Jiang HY
Carcinogenesis; 2019 Jul; 40(7):853-860. PubMed ID: 30877769
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic significance of genetic biomarkers in isocitrate dehydrogenase-wild-type lower-grade glioma: the need to further stratify this tumor entity - a meta-analysis.
Vuong HG; Tran TTK; Ngo HTT; Pham TQ; Nakazawa T; Fung KM; Hassell L; Katoh R; Kondo T
Eur J Neurol; 2019 Mar; 26(3):379-387. PubMed ID: 30298540
[TBL] [Abstract] [Full Text] [Related]
15. Anatomic mapping of molecular subtypes in diffuse glioma.
Tang Q; Lian Y; Yu J; Wang Y; Shi Z; Chen L
BMC Neurol; 2017 Sep; 17(1):183. PubMed ID: 28915860
[TBL] [Abstract] [Full Text] [Related]
16. Classification of adult diffuse gliomas by molecular markers-a short review with historical footnote.
Otani R; Uzuka T; Ueki K
Jpn J Clin Oncol; 2017 Jan; 47(1):2-6. PubMed ID: 27799281
[TBL] [Abstract] [Full Text] [Related]
17. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities.
Reuss DE; Kratz A; Sahm F; Capper D; Schrimpf D; Koelsche C; Hovestadt V; Bewerunge-Hudler M; Jones DT; Schittenhelm J; Mittelbronn M; Rushing E; Simon M; Westphal M; Unterberg A; Platten M; Paulus W; Reifenberger G; Tonn JC; Aldape K; Pfister SM; Korshunov A; Weller M; Herold-Mende C; Wick W; Brandner S; von Deimling A
Acta Neuropathol; 2015 Sep; 130(3):407-17. PubMed ID: 26087904
[TBL] [Abstract] [Full Text] [Related]
18. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
Weller M; Weber RG; Willscher E; Riehmer V; Hentschel B; Kreuz M; Felsberg J; Beyer U; Löffler-Wirth H; Kaulich K; Steinbach JP; Hartmann C; Gramatzki D; Schramm J; Westphal M; Schackert G; Simon M; Martens T; Boström J; Hagel C; Sabel M; Krex D; Tonn JC; Wick W; Noell S; Schlegel U; Radlwimmer B; Pietsch T; Loeffler M; von Deimling A; Binder H; Reifenberger G
Acta Neuropathol; 2015 May; 129(5):679-93. PubMed ID: 25783747
[TBL] [Abstract] [Full Text] [Related]
19. tert promoter mutations in sinonasal malignant melanoma: a study of 49 cases.
Jangard M; Zebary A; Ragnarsson-Olding B; Hansson J
Melanoma Res; 2015 Jun; 25(3):185-8. PubMed ID: 25746036
[TBL] [Abstract] [Full Text] [Related]
20. tert promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
Labussière M; Di Stefano AL; Gleize V; Boisselier B; Giry M; Mangesius S; Bruno A; Paterra R; Marie Y; Rahimian A; Finocchiaro G; Houlston RS; Hoang-Xuan K; Idbaih A; Delattre JY; Mokhtari K; Sanson M
Br J Cancer; 2014 Nov; 111(10):2024-32. PubMed ID: 25314060
[TBL] [Abstract] [Full Text] [Related]
